Author

Limin Zhang

Observed name: L. Zhang

Institutions: Harbin Medical University, Third Affiliated Hospital of Harbin Medical University

Observed institutions: Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, Jiangsu Cancer Hospital

ORCID: 0009-0004-5086-4285

Observed ORCID: 0009-0004-5086-4285

OpenAlex ID: A5072282220

65P Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase II, single-arm, exploratory research

2021 · J. Ma, J. Zhang, et al. · Annals of Oncology · 12

Geriatric nutritional risk index predicts the prognosis of gastric cancer patients treated with immune checkpoint inhibitors

2024 · Bao Liu, Limin Zhang · Medicine · 5

408P Proxalutamide plus endocrine therapy as a combination therapy in women with HR+/HER2-/AR+ metastatic breast cancer: A phase I study

2023 · H. Li, H. Jiang, et al. · Annals of Oncology · 1

Clostridium butyricum Supplementation Improved Growth Performance and Intestinal Health Through the Modulation of Intestinal Microbiome and Metabolites in Bull Calves

2024 · Jiaxiao Li, Lei Li, et al. · SSRN Electronic Journal

66P Camrelizumab combined with paclitaxel and nedaplatin in the first-line treatment of locally advanced/advanced esophageal squamous cell carcinoma: A phase II, single-arm, exploratory research

2021 · X. Wang, J. Ma, et al. · Annals of Oncology

Works count: 5

Citation count: 18

H-index: 2

I10-index: 1